Quadrant's gyms bulk up in Asia ahead of sale
![Quadrant executive chairman Chris Hadley and Fitness & Lifestyle Group CEO Greg Oliver,.](http://web.archive.org./web/20190130032016/https://www.afr.com/content/dam/images/h/0/z/b/o/c/image.related.afrIndexLead.320x210.h1ajrm.png/1548661563645.jpg)
Australia's biggest gyms business, Quadrant Private Equity's Fitness and Lifestyle Group, has spent more than $200 million on an acquisition in Asia, Street Talk can reveal.
Australia's biggest gyms business, Quadrant Private Equity's Fitness and Lifestyle Group, has spent more than $200 million on an acquisition in Asia, Street Talk can reveal.
ResMed shares dropped 8 per cent in early trading after its second-quarter revenue, which was up by 8 per cent, came in below expectations.
Mike Cannon-Brookes has made a career – and a fat fortune – with a 'no bullshit' approach that he's bringing to two election campaigns, he tells Lunch with the AFR.
Researchers are asking themselves how they can stop a repeat of a rogue Chinese scientist who created the first genetically edited babies - twins, born in November.
API chairman Mark Smith has defended the company's proposed $730 million cash and scrip offer for rival Sigma.
Researchers are trying new procedures to achieve something that transplant surgeons have dreamed of for more than 65 years – cut down on th...
API investor Andy Gracey says a proposal from the drug wholesaler to merge with Sigma Healthcare throws a lifeline to an under-pressure riva...
Philip Hampton has announced he will step down as chairman of GlaxoSmithKline just a month after the UK drug-maker announced a break-up that...
When two young scientists set out to create a new drug, the science turned out to be the easy part.
Stockbroker EverBlu Capital is in the market seeking to raise equity for ASX-listed medical cannabis hopeful Creso Pharma.
Get unlimited access to Australia's best business news and market insights, including our award-winning app.
Already a subscriber? Log in